Cargando…

WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study

OBJECTIVE: To evaluate the role of a WeChat-based mobile platform in growth hormone therapy. METHOD: Growth hormone therapy and health education information for height growth were embedded in a WeChat-based mobile platform, and the platform was evaluated through medical staff assessments, patient vo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qingling, Li, Ying, Su, Yajun, Huang, Liuhong, Liu, Jiajia, Lin, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259112/
https://www.ncbi.nlm.nih.gov/pubmed/37312945
http://dx.doi.org/10.1177/20552076231179849
_version_ 1785057598630789120
author Zhu, Qingling
Li, Ying
Su, Yajun
Huang, Liuhong
Liu, Jiajia
Lin, Weihua
author_facet Zhu, Qingling
Li, Ying
Su, Yajun
Huang, Liuhong
Liu, Jiajia
Lin, Weihua
author_sort Zhu, Qingling
collection PubMed
description OBJECTIVE: To evaluate the role of a WeChat-based mobile platform in growth hormone therapy. METHOD: Growth hormone therapy and health education information for height growth were embedded in a WeChat-based mobile platform, and the platform was evaluated through medical staff assessments, patient volunteer assessments and quantitative scoring criteria. RESULTS: In the medical staff evaluation, both clinicians and nurses had a positive attitude towards the mobile platform, believing that the design of the mobile platform was clearly visualized and easy to operate. In family volunteers’ evaluations, the summary of β-testing results showed that 90–100% of parents had a positive attitude towards the WeChat-based mobile platform. Parents of the patients and doctors and nurses assessed the mobile platform by reviewing quantitative scoring standards developed by professional researchers. All scores were >16 (the average score was 18–19.3). Children treated with growth hormone therapy were included for compliance tracking for one year, and patient adherence was described in this study. CONCLUSION: The interaction based on the WeChat platform and the health education of the public have greatly increased the interaction between doctors and patients, and improved patient satisfaction and compliance.
format Online
Article
Text
id pubmed-10259112
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-102591122023-06-13 WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study Zhu, Qingling Li, Ying Su, Yajun Huang, Liuhong Liu, Jiajia Lin, Weihua Digit Health Original Research OBJECTIVE: To evaluate the role of a WeChat-based mobile platform in growth hormone therapy. METHOD: Growth hormone therapy and health education information for height growth were embedded in a WeChat-based mobile platform, and the platform was evaluated through medical staff assessments, patient volunteer assessments and quantitative scoring criteria. RESULTS: In the medical staff evaluation, both clinicians and nurses had a positive attitude towards the mobile platform, believing that the design of the mobile platform was clearly visualized and easy to operate. In family volunteers’ evaluations, the summary of β-testing results showed that 90–100% of parents had a positive attitude towards the WeChat-based mobile platform. Parents of the patients and doctors and nurses assessed the mobile platform by reviewing quantitative scoring standards developed by professional researchers. All scores were >16 (the average score was 18–19.3). Children treated with growth hormone therapy were included for compliance tracking for one year, and patient adherence was described in this study. CONCLUSION: The interaction based on the WeChat platform and the health education of the public have greatly increased the interaction between doctors and patients, and improved patient satisfaction and compliance. SAGE Publications 2023-05-31 /pmc/articles/PMC10259112/ /pubmed/37312945 http://dx.doi.org/10.1177/20552076231179849 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Zhu, Qingling
Li, Ying
Su, Yajun
Huang, Liuhong
Liu, Jiajia
Lin, Weihua
WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study
title WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study
title_full WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study
title_fullStr WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study
title_full_unstemmed WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study
title_short WeChat-based mobile health management for short-stature children with long-term growth hormone therapy: A nonexperimental study
title_sort wechat-based mobile health management for short-stature children with long-term growth hormone therapy: a nonexperimental study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259112/
https://www.ncbi.nlm.nih.gov/pubmed/37312945
http://dx.doi.org/10.1177/20552076231179849
work_keys_str_mv AT zhuqingling wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy
AT liying wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy
AT suyajun wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy
AT huangliuhong wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy
AT liujiajia wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy
AT linweihua wechatbasedmobilehealthmanagementforshortstaturechildrenwithlongtermgrowthhormonetherapyanonexperimentalstudy